» Articles » PMID: 32384738

Breast Fibroblasts and ECM Components Modulate Breast Cancer Cell Migration Through the Secretion of MMPs in a 3D Microfluidic Co-Culture Model

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 May 10
PMID 32384738
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular matrix (ECM) composition greatly influences cancer progression, leading to differential invasion, migration, and metastatic potential. In breast cancer, ECM components, such as fibroblasts and ECM proteins, have the potential to alter cancer cell migration. However, the lack of in vitro migration models that can vary ECM composition limits our knowledge of how specific ECM components contribute to cancer progression. Here, a microfluidic model was used to study the effect of 3D heterogeneous ECMs (i.e., fibroblasts and different ECM protein compositions) on the migration distance of a highly invasive human breast cancer cell line, MDA-MB-231. Specifically, we show that in the presence of normal breast fibroblasts, a fibronectin-rich matrix induces more cancer cell migration. Analysis of the ECM revealed the presence of ECM tunnels. Likewise, cancer-stromal crosstalk induced an increase in the secretion of metalloproteinases (MMPs) in co-cultures. When MMPs were inhibited, migration distance decreased in all conditions except for the fibronectin-rich matrix in the co-culture with human mammary fibroblasts (HMFs). This model mimics the in vivo invasion microenvironment, allowing the examination of cancer cell migration in a relevant context. In general, this data demonstrates the capability of the model to pinpoint the contribution of different components of the tumor microenvironment (TME).

Citing Articles

Lymphoma-on-chip model reveals that lymph node stromal cells promote diffuse large B-cell lymphoma survival and migration.

Jouybar M, Mikula A, Zuidmeer N, Konijn T, de Jonge A, Roest H Mater Today Bio. 2025; 31:101544.

PMID: 40061210 PMC: 11889632. DOI: 10.1016/j.mtbio.2025.101544.


Studying breast cancer lung metastasis using a multi-compartment microfluidic device with a mimetic tumor-stroma interaction model.

Zarin B, Rafiee L, Abdollahi S, Vatani M, Hassani M, Sanati-Nezhad A Transl Oncol. 2025; 53:102303.

PMID: 39904278 PMC: 11847141. DOI: 10.1016/j.tranon.2025.102303.


Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling.

Ahmed T In Vitro Model. 2025; 2(1-2):1-23.

PMID: 39872875 PMC: 11756483. DOI: 10.1007/s44164-023-00043-2.


EMT-related cell-matrix interactions are linked to states of cell unjamming in cancer spheroid invasion.

van der Net A, Rahman Z, Bordoloi A, Muntz I, Ten Dijke P, Boukany P iScience. 2024; 27(12):111424.

PMID: 39717087 PMC: 11665421. DOI: 10.1016/j.isci.2024.111424.


A spheroid whole mount drug testing pipeline with machine-learning based image analysis identifies cell-type specific differences in drug efficacy on a single-cell level.

Vitacolonna M, Bruch R, Schneider R, Jabs J, Hafner M, Reischl M BMC Cancer. 2024; 24(1):1542.

PMID: 39696122 PMC: 11658419. DOI: 10.1186/s12885-024-13329-9.


References
1.
Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View

2.
Montanez-Sauri S, Sung K, Berthier E, Beebe D . Enabling screening in 3D microenvironments: probing matrix and stromal effects on the morphology and proliferation of T47D breast carcinoma cells. Integr Biol (Camb). 2013; 5(3):631-40. PMC: 3613432. DOI: 10.1039/c3ib20225a. View

3.
Velve-Casquillas G, Le Berre M, Piel M, Tran P . Microfluidic tools for cell biological research. Nano Today. 2010; 5(1):28-47. PMC: 2998071. DOI: 10.1016/j.nantod.2009.12.001. View

4.
Anguiano M, Castilla C, Maska M, Ederra C, Pelaez R, Morales X . Characterization of three-dimensional cancer cell migration in mixed collagen-Matrigel scaffolds using microfluidics and image analysis. PLoS One. 2017; 12(2):e0171417. PMC: 5293277. DOI: 10.1371/journal.pone.0171417. View

5.
Jimenez-Torres J, Virumbrales-Munoz M, Sung K, Lee M, Abel E, Beebe D . Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinoma. EBioMedicine. 2019; 42:408-419. PMC: 6491391. DOI: 10.1016/j.ebiom.2019.03.026. View